The role of stroma in prostatic carcinogenesis

Endocrine-Related Cancer

Volumn 5, Issue 4, 1998, Pages 253-270

  Grossfeld, G D ^a,b   Hayward, S W ^a   Tlsty, T D ^a   Cunha, G R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; CANCER INVASION; CARCINOGENESIS; CELL DIFFERENTIATION; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEDIATOR RELEASE; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; REVIEW; STROMA CELL; TUMOR GROWTH;

EID: 0032434047     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0050253     Document Type: Review

References (129)

1. Adam L, Crepin M, Lelong JC, Spanakis E & Israel L 1994 Selective interactions between mammary epithelial cells and fibroblasts in co-culture. International Journal of Cancer 59 262-268.
2. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA & Cunha GR 1994 Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proceedings of the National Academy of Sciences of the USA 91 1074-1078.
3. Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, Roberts AB & Sporn MB 1994 Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Research 54 4614-4617.
4. Atherton AJ, Monaghan P, Warburton MJ, Robertson D, Kenny AJ & Gusterson BA 1992 Dipeptidyl peptidase IV expression identifies a functional sub-population of breast fibroblasts. International Journal of Cancer 50 15-19.
5. Bao L, Loda M, Janmey PA, Stewart R, Anand-Apte B & Zeta-BR 1996 Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nature Medicine 12 1322-1328.
6. Baskin LS, Hayward SW, Young P & Cunha G 1996 Role of mesenchymal-epithelial interactions in bladder development. Journal of Urology 156 1820-1827.
7. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC & Chambon P 1990 A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348 699-704.
8. Becker KF, Atkinson MJ, Reich U, Huang HH, Nekarda H, Siewert JR & Hofler H 1993 Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Human Molecular Genetics 2 803-804.
9. Behrens J 1993 The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Research and Treatment 24 175-184.
10. Behrens J 1994 Cell contacts, differentiation, and invasiveness of epithelial cells. Invasion Metastasis 14 61-70.
11. Behrens J, Frixen U, Schipper J, Weidner M & Birchmeier W 1992 Cell adhesion in invasion and metastasis. Seminars in Cell Biology 3 169-178.
12. Bello D, Webber MM, Kleinman HK, Wartinger DD & Rhim JS 1997 Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 18 1215-1223.
13. Bigler SA, Deering RE & Brawer MK 1993 Comparison of microscopic vascularity in benign and malignant prostate tissue. Human Pathology 24 220-226.
14. Birchmeier W & Behrens J 1994 Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochimica et Biophysica Acta 1198 11-26.
15. Birchmeier W, Hulsken J & Behrens J 1995 E-cadherin as an invasion suppressor. Ciba Foundation Symposium 189 124-136.
16. Bosman FT, de Bruine A, Flohil C, van der Wurff A, ten Kate J & Dinjens WW 1993 Epithelial-stromal interactions in colon cancer. International Journal of Developmental Biology 37 203-211.
17. Bracke ME, Charlier C, Bruyneel EA, Labit C, Marcel MM & Castronovo V 1994 Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Research 54 4607-4609.
18. Brawer MK, Deering RE, Brown M, Preston SD & Bigler SA 1994 Predictors of pathologic stage in prostatic cacinoma. Cancer 73 678-687.
19. Brem H, Gresser I, Grosfeld J & Folkman J 1993 The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. Journal of Pediatric Surgery 28 1253-1257.
20. Bruchovsky N, Lesser B, van Doom EV & Craven S 1975 Hormonal effects on cell proliferation in rat prostate. Vitamins and Hormones 33 61-102.
21. Bussemakers MJ, van Bokhoven A, Mees SG, Kemler R & Schalken JA 1993 Molecular cloning and characterization of the human E-cadherin cDNA. Molecular Biology Reports 17 123-128.
22. Camps JL, Chang S-M, Hsu TC, Freeman MR, Hong S-J, Zhau HE, von Eschenbach AC & Chung LWK 1990 Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proceedings of the National Academy of Sciences of the USA 87 75-79.
23. Carter BS, Carter HB & Isaacs JT 1990 Epidemiologic evidence regarding predisposing factors to prostatic cancer. Prostate 16 187-197.
24. Carter BS, Steinberg GD, Beaty TH, Childs B & Walsh PC 1991 Familial risk factors for prostate cancer. In Prostate Cancer: Cell and Molecular Mechanisms in Diagnosis and Treatment, pp 5-13. Ed JT Issacs. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
25. Carter BS, Beaty TH, Steinberg GD, Childs B & Walsh PC 1992 Mendelian inheritance of familial prostate cancer. Proceedings of the National Academy of Sciences of the USA 89 3367-3371.
26. Catalona WJ & Smith DS 1994 5-Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancel. Journal of Urology 152 1837-1842.
27. Chiquet-Ehrismann R, Mackie EJ, Pearson CA & Sakakura T 1986 Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47 131-139.
28. Chodak GW, Thisted RA, Gerber GS, Johansson J-E, Adolfsson J, Jones GW, Chisholm GD, Moskovitz B, Livne PM & Warner J 1994 Results of conservative management of clinically localized prostate cancer. New England Journal of Medicine 330 242-248.
29. Chung LW 1991 Fibroblasts are critical determinants in prostatic cancer growth and dissemination. Cancer Metastasis Review 10 263-274.
30. Chung LWK, Chang S, Bell C, Zhau HE, Ro JY & Von Eschenbach AC 1989 Co-inoculation of tumorigenetic rat prostate mesenchymal cells with non-tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals. International Journal of Cancer 43 1179-1187.
31. Chung LWK, Gleave ME, Hsieh J-T, Hong S-J & Zhau HE 1991 Reciprocal mesenchymal-epithelial interaction affecting prostate tumour growth and hormonal responsiveness. In Prostate Cancer: Cell and Molecular Mechanisms in Diagnosis and Treatment, pp 91-122. Ed JT Isaacs. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
32. Cunha GR 1994 Role of mesenchymal-epithelial interactions in normal and abnormal development of male urogenital glands. In Ultrastructure of Male Urogenital Glands: Prostate, Seminal Vesicles, Urethral and Bulbourethral Glands, pp 15-34. Eds A Riva, F Testa-Riva & PM Motta. Boston, MA: Kluwer Academic Publishers.
33. Cunha GR & Young P 1991 Inability of Tfm (testicular feminization) epithelial cells to express androgen-dependent seminal vesicle secretory proteins in chimeric tissue recombinants. Endocrinology 128 3293-3298.
34. Cunha GR, Fujii H, Neubauer BL, Shannon JM, Sawyer LM & Reese BA 1983 Epithelial-mesenchymal interactions in prostatic development. I. Morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. Journal of Cell Biology 96 1662-1670.
35. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ & Sugimura Y 1987 The endocrinology and developmental biology of the prostate. Endocrine Reviews 8 338-363.
36. Cunha GR, Young P & Brody JR 1989 Role of uterine epithelium in the development of myometrial smooth muscle cells. Biology of Reproduction 40 861-871.
37. Cunha GR, Hayashi N & Wong YC 1991a Regulation of differentiation and growth of normal adult and neoplastic epithelia by inductive mesenchyme. In Prostate Cancer: Cell and Molecular Mechanisms in Diagnosis and Treatment, pp 73-90. Ed JT Issacs. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
38. Cunha GR, Young P, Higgins SJ & Cooke PS 1991b Neonatal seminal vesicle mesenchyme induces a new morphological and functional phenotype in the epithelia of adult ureter and ductus deferens. Development 111 145-158.
39. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL & Foster BA 1992a Normal and abnormal development of the male urogenital tract: role of androgens, mesenchymal-epithelial interactions and growth factors. Journal of Andrology 13 465-475.
40. Cunha GR, Battle E, Young P, Brody J, Donjacour A, Hayashi N & Kinbara H 1992b Role of epithelial-mesenchymal interactions in the differentiation and spatial organization of visceral smooth muscle. Epithelial Cell Biology 1 76-83.
41. Cunha GR, Hayward SW, Dahiya R & Foster BA 1996 Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. Acta Anatomica 155 63-72.
42. Dong G, Rajah R, Vu T, Hoffman AR, Rosenfeld RG, Roberts CT J, Peehl DM & Cohen P 1997 Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia. Journal of Clinical Endocrinology and Metabolism 82 2198-2203.
43. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT & Barrett JC 1995 KAII, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268 884-886.
44. Dong JT, Rinker-Schaeffer CW, Ichikawa T, Barrett JC & Isaacs JT 1996a Prostate cancer - biology of metastasis and its clinical implications. World Journal of Urology 14 182-189.
45. Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, Barrett JC & Isaacs JT 1996b Down-regulation of the KAII metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Research 56 4387-4390.
46. Donjacour AA & Cunha GR 1988 The effect of androgen deprivation on branching morphogenesis in the mouse prostate. Developmental Biology 128 1-14.
47. Donjacour AA & Cunha GR 1993 Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. Endocrinology 131 2342-2350.
48. Ellis MJ, Singer C, Hornby A, Rasmussen A & Cullen KJ 1994 Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Research and Treatment 31 249-261.
49. Fregene TA, Khanuja PS, Noto AC, Gehani SK, Van Egmont EM, Luz DA & Pienta KJ 1993 Tumor-associated angiogenesis in prostate cancer. Anticancer Research 13 2377-2382.
50. Giroldi LA & Schalken JA 1993 Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications. Cancer Metastasis Review 12 29-37.
51. Giroldi LA, Bringuier PP & Schalken JA 1994 Defective E-cadherin function in urological cancers: clinical implications and molecular mechanisms. Invasion Metastasis 14 71-81.
52. Cleave M, Hsieh JT, Gao CA, von Eschenbach AC & Chung LW 1991 Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Research 51 3753-3761.
53. Gleave ME, Hsieh JT, von Eschenbach AC & Chung LW 1992 Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. Journal of Urology 147 1151-1159.
54. Gold JS, Bao L, Ghoussoub RA, Zetter BR & Rimm DL 1997 Localization and quantitation of expression of the cell motility-related protein thymosin beta 15 in human breast milk tissue. Modern Pathology 10 1106-1112.
55. Haffen K, Kedinger M, Simon-Assmann PM & Lacroix B 1982 Mesenchyme-dependent differentiation of intestinal brush-border enzymes in the gizzard endoderm of the chick embryo. In Embryonic Development, Part B: Cellular Aspects, pp 261-270. Eds M Weber & M Burger. New York: A R Liss.
56. Hall MC, Troncoso P, Pollack A, Zhau HYE, Zagars GK, Chung LWK & von Eschenbach AC 1994 Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology 44 869-875.
57. Hanks GE, Lee WR & Schultheiss TE 1995 Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation. Journal of Urology 154 456-459.
58. Hay ED & Zuk A 1995 Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. American Journal of Kidney Disease 26 678-690.
59. Hayashi N & Cunha GR 1991 Mesenchyme-induced changes in neoplastic characteristics of the Dunning prostatic adeno-carcinoma. Cancer Research 51 4924-4930
60. Hayashi N, Cunha GR & Wong YC 1990 Influence of male genital tract mesenchymes on differentiation of Dunning prostatic adenocarcinoma. Cancer Research 50 4747-4754.
61. Hayashi N, Tsuji M, Sugimura Y, Kawamura J & Cunha GR 1996 Change in the morphological and functional cyto-differentiation induced by seminal vesicle mesenchyme in cell suspensions of rat Dunning prostatic adenocarcinoma cells. International Journal of Cancer 68 788-794.
62. Hayward SW, Dahiya R, Cunha GR, Bartek J, Despande N & Narayan P 1995 Establishment and characterization of an immortalized but non-tumorigenic human prostate epithelial cell line: BPH-1. In Vitro 31A 14-24.
63. Hayward SW, Baskin LS, Haughney PC, Foster BA, Cunha AR, Dahiya R, Prins GS & Cunha GR 1996a Stromal development in the ventral prostate, anterior prostate and seminal vesicle of the rat. Acta Anatomica 155 94-103.
64. Hayward SW, Cunha GR & Dahiya R 1996b Normal development and carcinogenesis of the prostate: a unifying hypothesis. Annals of the New York Academy of Sciences 784 50-62.
65. Hayward SW, Grossfeld GD, Haughney PC, Carroll PR & Cunha GR 1997a Differential effects of benign and tumor stromal cells on human prostate epithelium. Journal of Urology 157 (Suppl 4) 268.
66. Hayward SW, Rosen MA & Cunha GR 1997b Stromal-epithelial interactions in normal and neoplastic prostate. British Journal of Urology 79 (Suppl 2) 18-26.
67. Hayward SW, Haughney PC, Rosen MA, Gruelich KM, Weier H-U, Dahiya R & Cunha GR 1998 Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation 63 131-140.
68. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E & Dorshkind K 1997 Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO Journal 16 6926-6935.
69. Hulsken J, Behrens J & Birchmeier W 1994 Tumor-suppressor gene products in cell contacts: the cadherin-APC-armadillo connection. Current Opinion in Cell Biology 6 711-716.
70. Ichikawa T, Nihei N, Kuramochi H, Kawana Y, Killary AM, Rinker Schaeffer CW, Barrett JC, Isaacs JT, Kugoh H, Oshimura M & Shimazaki J 1996 Metastasis suppressor genes for prostate cancer. Prostate (Suppl) 6 31-35.
71. Isaacs WB 1995 Molecular genetics of prostate cancer. Cancer Surveys 25 357-379.
72. Isaacs WB, Bova GS, Morton RA, Bussemakers MJ, Brooks JD and Ewing CM 1994 Molecular biology of prostate cancer. Seminars in Oncology 21 514-521.
73. Isaacs WB, Bova GS, Morton RA, Bussemakers MJ, Brooks JD & Ewing CM 1995 Molecular biology of prostate cancer progression. Cancer Surveys 23 19-32.
74. Janvier R, Sourla A, Koutsilieris M & Doillon CJ 1997 Stromal fibroblasts are required for PC-3 human prostate cancer cells to produce capillary-like formation of endothelial cells in a three-dimensional co-culture system. Anticancer Research 17 1551-1558.
75. Jiang WG 1996 E-cadherin and its associated protein catenins, cancer invasion and metastasis. British Journal of Surgery 83 437-446.
76. Johansson J-E, Adami H-O, Andersson S-O, Bergström R, Holmberg L & Krusemo UB 1992 High 10-year survival rate in patients with early, untreated prostatic cancer. Journal of the American Medical Association 267 2191-2196.
77. Joos S, Bergerheim US, Pan Y, Matsuyama H, Bentz M, du Manoir S & Lichter P 1995 Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 14 267-276.
78. Kubota Y, Fujinami K, Uemura H, Dobashi Y, Miyamoto H, Iwasaki Y, Kitamura H & Shuin T 1995 Retinoblastoma gene mutations in primary human prostate cancer. Prostate 27 314-320.
79. Landis SH, Murray T, Bolden S & Wingo PA 1998 Cancer statistics 1998. CA-A Cancer Journal for Clinicians 48 6-7.
80. Larue L, Ohsugi M, Hirchenhain J & Kemler R 1994 E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proceedings of the National Academy of Sciences of the USA 91 8263-8267.
81. Manni A, Badger B, Wei L, Zaenglein A, Grove R, Khin S, Heitjan D, Shimasaki S & Ling N 1994 Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions. Cancer Research 54 2934-2942.
82. Mareel M, Behrens J, Birchmeier W, De Bruyne GK, Vleminckx K, Hoogewus A, Fiers WC & Van Roy F 1991 Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. International Journal of Cancer 47 922-928.
83. Montironi R, Galluzzi CM, Diamanti L, Taborro R, Scarpelli M & Pisani E 1993 Prostatic intra-epithelial neoplasia. Qualitative and quantitative analyses of the blood capillary architecture on thin tissue sections. Pathology Research and Practice 189 542-548.
84. Morton RA, Ewing CM, Nagafuchi A, Tsukita S & Isaacs WB 1993 Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Research 53 3585-3590.
85. Morton RA, Ewing CM, Watkins JJ & Isaacs WB 1995 The E-cadherin cell-cell adhesion pathway in urologie malignancies. World Journal of Urology 13 364-368.
86. Nemeth JA & Lee C 1996 Prostatic ductal system in rats: regional variation in stromal organization. Prostate 28 124-128.
87. Peehl DM 1993 Oncogenes in prostate cancer. Cancer 71 1159-1164.
88. Peehl DM, Cohen P & Rosenfeld RG 1995 The insulin-like growth factor system in the prostate. World Journal of Urology 13 306-311.
89. Perl A-K, Wilgenbus P, Dahl U, Semb H & Christofori G 1998 A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392 190-193.
90. Ponten F, Ren Z, Nister M, Westermark B & Ponten J 1994 Epithelial-stromal interactions in basal cell cancer: the PDGF system. Journal of Investigative Dermatology 102 304-309.
91. Poulsom R, Pignatelli M, Stetler-Stevenson W, Liotta LA, Wright PA, Jeffery RE, Longcroft JM, Rogers L & Stamp GWH 1992 Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. American Journal of Pathology 141 389-396.
92. Poulsom R, Hanby AM, Pignatelli M, Jeffery RE, Longcroft JM, Rogers L & Stamp GWH 1993 Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. Journal of Clinical Pathology 46 429-436.
93. Risinger JI, Berchuck A, Kohler MF & Boyd J 1994 Mutations of the E-cadherin gene in human gynecologic cancers. Nature Genetics 7 98-102.
94. Ronnov-Jessen L, Peterson O & Bissell M 1996 Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiological Reviews 76 69-125.
95. Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, Old LJ & Rettig WJ 1994 Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proceedings of the National Academy of Sciences of the USA 91 5657-5661.
96. Schor SL, Schor AM, Grey AM & Rushton G 1988a Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells. Journal of Cell Science 90 391-399.
97. Schor SL, Schor AM & Rushton G 1988b Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics. Journal of Cell Science 90 401-407.
98. Schor SL, Grey AM, Picardo M, Schor AM, Howell A, Ellis I & Rushton G 1991 Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): implications for cancer pathogenesis. In Cell Motility Factors, pp 127-146. Ed ID Goldberg. Basel: Berkhäuser Verlag.
99. Shiozaki H, Oka H, Inoue M, Tamura S & Monden M 1996 E-cadherin mediated adhesion system in cancer cells. Cancer 77 1605-1613.
100. Siegal JA, Yu E & Brawer MK 1995 Topography of neovascularity in human prostate carcinoma. Cancer 75 2545-2551.
101. Silberman MA, Partin AW, Veltri RW & Epstein JI 1997 Tumor angiogenesis correlates wtih progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer 79 772-779.
102. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT & Cullen KJ 1995 Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Research 55 2448-2454.
103. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM & Isaacs WB 1996 Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274 1371-1374.
104. Stamey T & McNeal J 1992 Adenocarcinoma of the prostate. In Campbell's Urology, pp 1159-1221. Eds P Walsh, A Retik, T Stamey & JE Vaughn. Philadelphia: WB Saunders Co.
105. Sugimura Y, Foster BA, Hom YK, Rubin JS, Finch PW, Aaronson SA, Hayashi N, Kawamura J & Cunha GR 1996 Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. International Journal of Developmental Biology 40 941-951.
106. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB & Bova GS 1998 Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Research 58 204-209.
107. Takeichi M 1988 The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 102 639-655.
108. Tam NNC, Phil M, Wang YZ & Wong YC 1997 The influence of mesenchyme of neonatal seminal vesicle and embryonic urogenital sinus on the morphologic and functional cytodifferentiation of Dunning prostatic adenocarcinoma: roles of growth factors and proto-oncogenes. Urologic Oncology 3 85-93.
109. Tennant MK, Thrasher JB, Twomey PA, Drivdahl RH, Birnbaum RS & Plymate SR 1996 Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared with benign prostate epithelium. Journal of Clinical Endocrinology and Metabolism 81 3774-3782.
110. Thompson TC 1990 Growth factors and oncogenes in prostate cancer. Cancer Cells 11 345-354.
111. Thompson TC, Southgate J, Kitchener G & Land H 1989 Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 56 917-930.
112. Thompson TC, Timme TL, Kadmon D, Park SH, Egawa S & Yoshida K 1993a Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate. Molecular Carcinogenesis 7 165-179.
113. Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT & Park SH 1993b Transgenic models for the study of prostate cancer. Cancer 71 1165-1171.
114. Thomson AA, Foster BA & Cunha GR 1997 Analysis of growth factor and receptor mRNAs during development of the rat seminal vesicle and prostate. Development 124 2431-2439.
115. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM & Isaacs WB 1992 Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Research 52 5104-5109.
116. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM & Schalken JA 1994 Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Research 54 3929-3933.
117. Vandenbossche GM, De Bruyne GK, Bruyneel EA, Clemminck G, Vleminckx K, Van Roy FM & Mareel MM 1994 Microencapsulation of MDCK-ras-e cells prevents loss of E-cadherin invasion-suppressor function in vivo. International Journal of Cancer 57 73-80.
118. Vleminckx K, Vakaet L, Mareel M, Fiers W & Van Roy F 1991 Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66 107-119.
119. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S & Ushigome S 1992 Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastatis: a morphometric study. Journal of Pathology 168 257-262.
120. Walsh PC, Partin AW & Epstein JI 1994 Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. Journal of Urology 152 1831-1836.
121. Wang YZ & Wong YC 1997 Oncogenes and tumor suppressor genes in prostate cancer: a review. Urologic Oncology 3 41-46.
122. Webber MM, Bello D, Kleinman HK & Hoffman MP 1997 Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells. Carcinogenesis 18 1225-1231.
123. Weidner N, Carroll PR, Flax J, Blumenfeld W & Folkman J 1993 Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. American Journal of Pathology 143 401-409.
124. Wong YC, Cunha GR & Hayashi N 1992 Effects of mesenchyme of embryonic urogenital sinus and neonatal seminal vesicle on the cytodifferentiation of the Dunning tumor: ultrastructural study. Acta Anatomica 143 139-150.
125. Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S & Chung LW 1994 Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. International Journal of Cancer 57 406-412.
126. Yan G, Fukabori Y, Nikolaropoulos S, Wang F & McKeehan WL 1992 Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Molecular Endocrinology 6 2123-2128.
127. Yan G, Fukabori Y, McBride G, Nikolaropolous S & McKeehan W 1993 Exon switching and activation of stromal and embryonic FGF/FGF receptor genes in prostate epithelial cells accompanies stromal independence and malignancy. Molecular and Cellular Biology 13 4513-4522.
128. Zagars GK & Pollack A 1995 Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome. Urology 45 476-483.
129. Zietman AL, Coen JJ, Shipley WU, Willett CG & Efird JT 1994 Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome. Journal of Urology 151 640-650.